CCL2 is called a “tumor-derived chemotactic factor.” It recruits several classes of immune cells like monocytes, dendritic cells, memory T cells, and natural killer cells (Fig. 2), whereby pro-inflammatory mechanisms are modulated and neo-angiogenesis is increased [61]. This evidence concerns the gene CCL2 and neoplasm.